Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
Holding APRE?
Track your performance easily

Aprea Therapeutics (APRE) Financial Statements

443 Followers

Aprea Therapeutics Financial Overview

Aprea Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.033; its P/E ratio is -1.29; Aprea Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 561.57K$ 380.57K$ 14.07K$ 319.47K-
Gross Profit$ 561.57K$ 380.57K$ 14.07K$ 319.47K-
EBIT$ -3.47M$ -2.81M$ -3.44M$ -3.20M$ -3.26M
EBITDA$ -3.46M$ -2.80M$ -3.44M-$ -3.26M
Net Income Common Stockholders$ -3.47M$ -2.81M$ -3.44M$ -3.20M$ -3.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 28.69M$ 32.37M$ 21.61M$ 25.35M$ 27.69M
Total Assets$ 29.96M$ 33.20M$ 22.65M$ 25.77M$ 28.68M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -28.69M$ -32.37M$ -21.61M$ -25.35M$ -27.69M
Total Liabilities$ 4.41M$ 4.28M$ 5.70M$ 5.48M$ 5.26M
Stockholders Equity$ 25.56M$ 28.92M$ 16.95M$ 20.29M$ 23.42M
Cash Flow-
Free Cash Flow$ -3.65M$ -3.94M$ -3.75M-$ -3.22M
Operating Cash Flow$ -3.64M$ -3.94M$ -3.74M$ -2.24M$ -3.22M
Investing Cash Flow$ -7.50K$ -7.98K$ -7.15K$ -85.94K-
Financing Cash Flow$ -21.06K$ 14.71M---
Currency in USD

Aprea Therapeutics Earnings and Revenue History

Aprea Therapeutics Debt to Assets

Aprea Therapeutics Cash Flow

Aprea Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis